Tech Company Financing Transactions

Supernus Pharmaceuticals Funding Round

Flybridge Capital Partners, North Bridge Venture Partners and Pilot House Ventures Group participated in a $7 million funding round for Supernus Pharmaceuticals. The round was announced on 3/30/2005.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1550 East Gude Drive
Rockville, MD 20850
USA

Phone

(301) 838-2500

Website

www.supernus.com

Email Address

Not Recorded

Overview

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) is a specialty pharmaceuticals company that has a portfolio of proven and patented drug delivery technologies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jack Khattar

        

Chief Financial Officer

Gregory Patrick

        

Chief Medical Officer

Stefan Schwabe

        

VP - Marketing

Todd Horich

        

Browse more venture capital transactions:

Prev: 3/30/2005: GroundWork Open Source venture capital transaction
Next: 3/30/2005: Akustica venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary